JESSICA STENDEL: Open Payments
NPI 1427042639 · CLOVIS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$517 in 27 payments from 11 companies in 2025. Trend: 2023 $848 · 2024 $994 · 2025 $517
Food & beverage: $517
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $155 |
| AstraZeneca Pharmaceuticals LP | 5 | $110 |
| GlaxoSmithKline, LLC. | 3 | $64 |
| Amgen Inc. | 2 | $36 |
| Novo Nordisk Inc | 1 | $30 |
| Radius Health, Inc. | 1 | $27 |
| Hologic Sales and Service, LLC | 1 | $24 |
| PFIZER INC. | 1 | $23 |
| Exact Sciences Corporation | 1 | $19 |
| Dexcom, Inc. | 1 | $16 |
Products named: UBRELVY, FARXIGA, SYNTHROID, AIRSUPRA, TRELEGY ELLIPTA, Ozempic, APTIMA, NURTEC ODT.
Industry payments across CA — which companies pay providers there.
